First, genomic data showed that, next to VHL alterations (93.1%), most common driver gene mutations in ccRCC included alterations in tumor suppressor genes of different pathways such as SETD2 (90.3%) and PTEN (30.6%). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.